STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

被引：0
|
作者：
Cosimo Lobello
Boris Tichy
Vojtech Bystry
Lenka Radova
Daniel Filip
Marek Mraz
Ivonne-Aidee Montes-Mojarro
Nina Prokoph
Hugo Larose
Huan-Chang Liang
Geeta G. Sharma
Luca Mologni
David Belada
Katerina Kamaradova
Falko Fend
Carlo Gambacorti-Passerini
Olaf Merkel
Suzanne D. Turner
Andrea Janikova
Sarka Pospisilova
机构：
[1] Masaryk University,Center of Molecular Medicine, Central European Institute of Technology (CEITEC)
[2] University Hospital Brno and Medical Faculty MU,Department of Internal Medicine—Hematology and Oncology
[3] Eberhard Karls University,Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen
[4] University of Cambridge,Division of Cellular and Molecular Pathology, Department of Pathology
[5] Medical University of Vienna,Department of Pathology
[6] University of Milano-Bicocca,Department of Medicine and Surgery
[7] Charles University Hospital and Faculty of Medicine,4th Department of Internal Medicine—Hematology
[8] Charles University Hospital and Faculty of Medicine,Fingerland Department of Pathology
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1500 / 1505
页数：5
相关论文
共 50 条
  • [41] Jak3 contributes to the activation of ALK and Stat3 in ALK+ anaplastic large cell lymphoma
    Amin, HM
    Lin, Q
    Lai, R
    LABORATORY INVESTIGATION, 2006, 86 (04) : 417 - 419
  • [42] Anaplastic large cell lymphoma with axial skeletal lesions portends a poor prognosis
    Al-Asaadi, Zahra
    Fatin, Sammour
    Patel, Ketan
    Chetty, Naren
    Dubrey, Simon
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (10) : 606 - 607
  • [43] TP53 MUTATIONS BUT NOT ATM MUTATIONS ASSOCIATE WITH HIGHER IN VITRO RESISTANCE OF CLL CELLS TO RITUXIMAB
    Sebejova, L.
    Sramek, M.
    Jaskova, Z.
    Malcikova, J.
    Navrkalova, V.
    Borsky, M.
    Doubek, M.
    Mayer, J.
    Pospisilova, S.
    Trbusek, M.
    HAEMATOLOGICA, 2013, 98 : 403 - 403
  • [44] Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?
    Cencini, Emanuele
    Fabbri, Alberto
    Raspadori, Donatella
    Gozzetti, Alessandro
    Bocchia, Monica
    BLOOD RESEARCH, 2021, 56 (04) : 333 - 334
  • [45] TP53 Mutations in Esophageal Squamous Cell Carcinoma
    Zhong, Leqi
    Li, Hongmu
    Chang, Wuguang
    Ao, Yong
    Wen, Zhesheng
    Chen, Youfang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (09):
  • [46] TP53 Mutations in Nonsmall Cell Lung Cancer
    Mogi, Akira
    Kuwano, Hiroyuki
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [47] STAT3 Predicts Poor Outcome In Patients With Advanced Diffuse Large B Cell Lymphoma
    Feng, Ru
    Wei, Xiaolei
    Xu, Meng
    Huang, Fen
    Wei, Yongqiang
    Zhao, Tong
    Ye, B. Hilda
    BLOOD, 2013, 122 (21)
  • [48] Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
    He Li
    Lei Yang
    Yuanyuan Wang
    Lingchan Wang
    Gang Chen
    Li Zhang
    Dongchang Wang
    BMC Bioinformatics, 24
  • [49] Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma (vol 27, pg 516, 2015)
    Crescenzo, Ramona
    Abate, Francesco
    Lasorsa, Elena
    Tabbo', Fabrizio
    Gaudiano, Marcello
    Chiesa, Nicoletta
    Di Giacomo, Filomena
    Spaccarotella, Elisa
    Barbarossa, Luigi
    Ercole, Elisabetta
    Todaro, Maria
    Boi, Michela
    Acquaviva, Andrea
    Ficarra, Elisa
    Novero, Domenico
    Rinaldi, Andrea
    Tousseyn, Thomas
    Rosenwald, Andreas
    Kenner, Lukas
    Cerroni, Lorenzo
    Tzankov, Alexander
    Ponzoni, Maurilio
    Paulli, Marco
    Weisenburger, Dennis
    Chan, Wing C.
    Iqbal, Javeed
    Piris, Miguel A.
    Zamo', Alberto
    Ciardullo, Carmela
    Rossi, Davide
    Gaidano, Gianluca
    Pileri, Stefano
    Tiacci, Enrico
    Falini, Brunangelo
    Shultz, Leonard D.
    Mevellec, Laurence
    Vialard, Jorge E.
    Piva, Roberto
    Bertoni, Francesco
    Rabadan, Raul
    Inghirami, Giorgio
    CANCER CELL, 2015, 27 (05) : 744 - 744
  • [50] Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
    Li, He
    Yang, Lei
    Wang, Yuanyuan
    Wang, Lingchan
    Chen, Gang
    Zhang, Li
    Wang, Dongchang
    BMC BIOINFORMATICS, 2023, 24 (01)
12345